The US Food and Drug Administration (FDA) has this week approved the first drug since 2003 to treat Alzheimer’s disease. Aducanumab, created by US pharmaceutical company Biogen, is an antibody designed to target amyloid, a protein that builds up in the brains of people with early stages of Alzheimer’s disease. Whereas other existing treatments help […]

It is well documented that music and singing are beneficial to those living with dementia. Listening to or singing songs can provide both behavioural and emotional benefits and the power of music can unlock memories and help provide links to a person’s past and promote connection with carers. Researchers at Nottingham University are looking for […]

Alzheimer’s disease affects approximately 70% of people diagnosed with dementia, and an estimated 26 million people worldwide. In the very early stages, Alzheimer’s disease may be referred to or diagnosed as Mild Cognitive Impairment (MCI). There are no available treatments to prevent or delay the start of Alzheimer’s disease and currently medications only provide a […]

As we turn six today, we are celebrating not only six years of bringing researchers and volunteers together, but also our collective achievement of helping dementia research to keep going during the pandemic.   See what our volunteers, charity partners and researchers have to say about us!   Since Join Dementia Research began, an incredible […]

An Alzheimer’s drug study is restarting after being paused earlier this year. The CLARITY study is examining whether the drug BAN2401 can be effective in preventing or delaying the very early stages of Alzheimer’s disease.  Alzheimer’s disease affects approximately 26 million people worldwide and current medications only provide a temporary improvement in symptoms. Who can […]

This year’s theme for World Alzheimer’s Day is “Let’s Talk About Dementia”, and it’s more important than ever that we continue to advance dementia care and treatments. Research is the best hope to do this. You can see if you are eligible to take part in our studies by registering or logging into Join Dementia Research.

A recent study has found that the risk of dying from neurodegenerative disease is almost 3.5 times higher for footballers. However research is at an early stage and there’s currently no suggestion that anyone should stop playing football. Regular physical activity – including football – is a good way to reduce the risk of dementia and conditions such as heart disease.

In a new study, researchers designed a bathing cap-style head device, called the MemorEM, which was used to deliver electromagnetic waves to the brain. The purpose of this was to try to dissolve what are known as oligomers – groups of abnormal proteins – as they were forming. There was some sign of improvements on tests of thinking and memory in most of the people taking part in the study. This is an experimental, early-stage study that looked primarily at safety, so it cannot tell us for sure if the treatment works.

Researchers have identified a new form of dementia. Known as LATE, it shares many similarities with Alzheimer’s disease, but tends to lead to a more gradual decline in memory. LATE (limbic-predominant age-related TDP-43 encephalopathy) appears to be linked to the accumulation of a protein called TDP-43 in the brain, whereas Alzheimer’s is linked to the […]

This article has been reproduced from the NHS website. “Gum disease bug could play ‘central role’ in development of Alzheimer’s,” The Independent reports. The causes of Alzheimer’s disease are still debated. Most scientists think it is likely to be down to a combination of factors, including your genes and lifestyle. But some believe it may be […]